Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Diabetes

Free Subscription Articles published in Am J Manag Care Retrieve available abstracts of 23 articles: HTML format

Single Articles

September 2025
1. KAUR M, Ives B, Mijanovich T, Singh P, et al
   Workforce innovation reduces Medicaid costs in chronic care.
   Am J Manag Care. 2025;31.
   PubMed     Abstract available
   
   
   
2. LIU G, Jarema M, Mo M, Stievater T, et al
   Navigating compounded semaglutide: what health care providers need to know.
   Am J Manag Care. 2025;31:480-484.
   PubMed     Abstract available
   
   
   August 2025
3. UKHANOVA M, Wozny JS, Truong CN, Ghosh L, et al
   Trends in glucagon-like peptide 1 receptor agonist prescribing patterns.
   Am J Manag Care. 2025;31:e228-e234.
   PubMed     Abstract available
   
   
   
4. TREMBLAY ES, Argetsinger S, Zhang F, Ross-Degnan D, et al
   Trends in insulin out-of-pocket costs and use disparities, 2008-2021.
   Am J Manag Care. 2025;31:408-412.
   PubMed     Abstract available
   
   
   April 2025
5. MARRERO DG, Parkin CG, Aleppo G, Hirsch IB, et al
   The role of advanced technologies in improving diabetes outcomes.
   Am J Manag Care. 2025;31:e102-e112.
   PubMed     Abstract available
   
   
   
6. KOMMAREDDI M, Wherry K
   Cost-effectiveness of the MiniMed 780G system for type 1 diabetes.
   Am J Manag Care. 2025;31:e79-e86.
   PubMed     Abstract available
   
   
   
7. NEMLEKAR PM, Hannah KL, Green CR, Grace T, et al
   Combined effect of continuous glucose monitoring and semaglutide: analysis of administrative claims.
   Am J Manag Care. 2025;31:183-188.
   PubMed     Abstract available
   
   
   March 2025
8. ABRAHAM JM, Ambroz T, Chacon M, Kidney RSM, et al
   Real-world digitally based diabetes management program implementation by a large employer.
   Am J Manag Care. 2025;31:e62-e68.
   PubMed     Abstract available
   
   
   January 2025
9. VILLAVERDE Z, Hinman RH 2nd, Grimes RM
   Physiologic insulin resensitization lowers cost in patients with diabetes and kidney disease.
   Am J Manag Care. 2025;31:e11-e14.
   PubMed     Abstract available
   
   
   
10. ERNST K, Thompson AN, Bensami A, Choe HM, et al
    Collaboration to transition members to preferred formulary dipeptidyl-peptidase-4 inhibitor.
    Am J Manag Care. 2025;31:20-24.
    PubMed     Abstract available
    
    
    December 2024
11. NEELAND IJ, Rajagopalan S
    A team-based approach to type 2 diabetes and cardiovascular care.
    Am J Manag Care. 2024;30.
    PubMed     Abstract available
    
    
    
12. HANDELSMAN Y
    Diabetes, cardiorenal, and metabolic multispecialty practice recommendations and early intensive management of cardio-renal-metabolic disease.
    Am J Manag Care. 2024;30.
    PubMed     Abstract available
    
    
    
13. FERDINAND KC
    An overview of cardiovascular-kidney-metabolic syndrome.
    Am J Manag Care. 2024;30.
    PubMed     Abstract available
    
    
    September 2024
14. BETTS KA, Oberprieler NG, Wu A, James G, et al
    Antihyperglycemic treatment patterns for chronic kidney disease and type 2 diabetes.
    Am J Manag Care. 2024;30:405-412.
    PubMed     Abstract available
    
    
    August 2024
15. HUANG HC, Touchette DR, Tadrous M, Schumock GT, et al
    Adherence patterns 1 year after initiation of SGLT2 inhibitors: results of a national cohort study.
    Am J Manag Care. 2024;30:e226-e232.
    PubMed     Abstract available
    
    
    May 2024
16. POONAWALLA IB, Chung L, Shetler S, Pearce H, et al
    Medication adherence star ratings measures, health care resource utilization, and cost.
    Am J Manag Care. 2024;30:210-217.
    PubMed     Abstract available
    
    
    
17. NOBLE M, Chen F, Linke S, Dall TM, et al
    Modeling the economic value of cardiometabolic virtual-first care programs.
    Am J Manag Care. 2024;30.
    PubMed     Abstract available
    
    
    April 2024
18. CHOE JH, Xuan S, Goldenberg A, Matian J, et al
    Medication persistence and its impact on type 2 diabetes.
    Am J Manag Care. 2024;30:e124-e134.
    PubMed     Abstract available
    
    
    
19. KUMAR A, Dowd-Green C, Green R, Stewart R, et al
    Institutional practices for charitable medication access for uninsured patients.
    Am J Manag Care. 2024;30:e135-e139.
    PubMed     Abstract available
    
    
    March 2024
20. HOFFMAN AF, Roberson CL, Cohen P, Jackson VL, et al
    Improving glycemic control in diabetes through virtual interdisciplinary rounds.
    Am J Manag Care. 2024;30:e78-e84.
    PubMed     Abstract available
    
    
    
21. QUACH J, Midlam C, Sell C, Levin-Scherz J, et al
    Out-of-pocket costs for diabetes medications in employer-sponsored health insurance plans.
    Am J Manag Care. 2024;30:107-108.
    PubMed     Abstract available
    
    
    
22. LAMONICA LC, Ren J, Jain N, Goldberg ES, et al
    At-home hemoglobin A1c testing during COVID-19 improved glycemic control.
    Am J Manag Care. 2024;30:e73-e77.
    PubMed     Abstract available
    
    
    
23. LO JC, Chandra M, Yang W, Thompson N, et al
    Challenges of fracture risk assessment in Asian and Black women.
    Am J Manag Care. 2024;30:140-144.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.